SG Stock MarketDetailed Quotes
HQXW IX BiopharmaW260718
- 0.004
- 0.0000.00%
10min DelayMarket Closed Sep 18 09:18 CST
3.53MMarket Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.004Pre Close0.00Turnover0.01052wk High0.00%Turnover Ratio883.34MShares0.00152wk Low--EPS TTM1.72MFloat Cap0.010Historical High0.00P/E (Static)430.72MShs Float0.001Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B100Lot Size--Div YieldTTM
IX BiopharmaW260718 Key Stats
EPS
According to the latest financial report of IX BiopharmaW260718, the latest earnings per share (TTM) for the company is --. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: SGD
Quarterly
Loading...
FCF
Interested in knowing about IX BiopharmaW260718's free cash flow? The latest report shows it as -2.75M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: SGD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of IX BiopharmaW260718 shows that the company's current ratio is 1.38, indicating healthy liquidity.
Currency: SGD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of IX BiopharmaW260718, the quick ratio is 1.20, indicating that the company can meet its short-term debt obligations.
Currency: SGD
Quarterly
Loading...
ROE
Want to learn more about the financial health of IX BiopharmaW260718? The latest ROE figure is -14.78%, indicating that the company has stable profitability.
Currency: SGD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of IX BiopharmaW260718, the total asset return on investment (ROA) is -10.68%.
Currency: SGD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check IX BiopharmaW260718's latest financial report to see how their gross margin is doing - currently at -91.95%.
Currency: SGD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of IX BiopharmaW260718, the net profit margin is -1.39K%, which is a good sign for its profitability.
Currency: SGD
Quarterly
Loading...
Heat List
SG
Overall
Symbol
Price
% Chg
No Data